CoChat

Tyrosine kinase inhibition increases functional parkin‐ Beclin‐1 interaction and enhances amyloid clearance and cognitive performance

Open access
Lonskaya, Irina, Hebron, Michaeline L., Desforges, Nicole M., Franjie, Alexander, Moussa, Charbel E.‐H. · 2013 · EMBO Molecular Medicine
Cited by 140

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Tyrosine kinase inhibitors (TKIs) are effective therapies for leukaemia. Alzheimer is a neurodegenerative disease characterized by accumulation of β-amyloid (plaques) and hyper-phosphorylated Tau (tangles). Here we show that AD animals have high levels of insoluble parkin and decreased parkin-Beclin-1 interaction, while peripheral administration of TKIs, including Nilotinib and Bosutinib, increases soluble parkin leading to amyloid clearance and cognitive improvement. Blocking Beclin-1 expression with shRNA or parkin deletion prevents tyrosine kinase (TK) inhibition-induced amyloid clearance, suggesting that functional parkin-Beclin-1 interaction mediates amyloid degradation. Isolation of autophagic vacuoles (AVs) in AD mouse brain shows accumulation of parkin and amyloid, consistent with previous results in AD brains, while Bosutinib and Nilotinib increase parkin-Beclin-1 interaction and result in protein deposition in the lysosome. These data suggest that decreased parkin solubility impedes parkin-Beclin-1 interaction and amyloid clearance. We identified two FDA-approved anti-cancer drugs as potential treatment for AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201302771

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 140

Metadata

Authors
Lonskaya, I., Hebron, M. L., Desforges, N. M., Franjie, A., & Moussa, C. E. ‐.
Venue
EMBO Molecular Medicine
Published
2013-07-04
Volume
5
Issue
8
Pages
1247-1262
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W1883048423
Cited by
140
References
20
FWCI
6.73
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tyrosine kinase inhibition increases functional parkin‐ Beclin‐1 interaction and enhances amyloid clearance and cognitive performance. https://app.cochat.ai/papers/10.1002/emmm.201302771
The paper
Lonskaya, I., Hebron, M. L., Desforges, N. M., Franjie, A., & Moussa, C. E. ‐. (2013). Tyrosine kinase inhibition increases functional parkin‐ Beclin‐1 interaction and enhances amyloid clearance and cognitive performance. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201302771

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.